
Catherine Ho
Examiner (ID: 13990)
| Most Active Art Unit | 2924 |
| Art Unit(s) | 2953, 2924 |
| Total Applications | 1329 |
| Issued Applications | 1227 |
| Pending Applications | 20 |
| Abandoned Applications | 93 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16175594
[patent_doc_number] => 20200222562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => STABILIZATION OF RADIOPHARMACEUTICAL COMPOSITIONS USING ASCORBIC ACID
[patent_app_type] => utility
[patent_app_number] => 16/551588
[patent_app_country] => US
[patent_app_date] => 2019-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7473
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16551588
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/551588 | STABILIZATION OF RADIOPHARMACEUTICAL COMPOSITIONS USING ASCORBIC ACID | Aug 25, 2019 | Abandoned |
Array
(
[id] => 17140276
[patent_doc_number] => 20210308287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => METHOD FOR EXTRACTION AND PURIFICATION OF 68GA
[patent_app_type] => utility
[patent_app_number] => 17/265138
[patent_app_country] => US
[patent_app_date] => 2019-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9600
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -89
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17265138
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/265138 | Method for extraction and purification of 68GA | Aug 1, 2019 | Issued |
Array
(
[id] => 15087059
[patent_doc_number] => 20190338340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => 5,5-DISUBSTITUTED LUCIFERINS AND THEIR USE IN LUCIFERASE-BASED ASSAYS
[patent_app_type] => utility
[patent_app_number] => 16/516974
[patent_app_country] => US
[patent_app_date] => 2019-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16674
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16516974
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/516974 | 5,5-disubstituted luciferins and their use in luciferase-based assays | Jul 18, 2019 | Issued |
Array
(
[id] => 17805875
[patent_doc_number] => 20220257710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => ANTI-INFECTION EFFECTS OF HNRNPA2B1 AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/627805
[patent_app_country] => US
[patent_app_date] => 2019-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7543
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17627805
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/627805 | ANTI-INFECTION EFFECTS OF HNRNPA2B1 AND USE THEREOF | Jul 16, 2019 | Pending |
Array
(
[id] => 16969404
[patent_doc_number] => 11065351
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Methods for diagnosing and monitoring eosinophilic esophagitis
[patent_app_type] => utility
[patent_app_number] => 16/502328
[patent_app_country] => US
[patent_app_date] => 2019-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10971
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16502328
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/502328 | Methods for diagnosing and monitoring eosinophilic esophagitis | Jul 2, 2019 | Issued |
Array
(
[id] => 17406079
[patent_doc_number] => 11246940
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-15
[patent_title] => Peptides whose uptake in cells is controllable
[patent_app_type] => utility
[patent_app_number] => 16/457763
[patent_app_country] => US
[patent_app_date] => 2019-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 39792
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16457763
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/457763 | Peptides whose uptake in cells is controllable | Jun 27, 2019 | Issued |
Array
(
[id] => 14991141
[patent_doc_number] => 20190314528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => TARGETED THERAPEUTICS
[patent_app_type] => utility
[patent_app_number] => 16/454586
[patent_app_country] => US
[patent_app_date] => 2019-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16454586
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/454586 | TARGETED THERAPEUTICS | Jun 26, 2019 | Abandoned |
Array
(
[id] => 14990653
[patent_doc_number] => 20190314284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => Cleavable Lipids
[patent_app_type] => utility
[patent_app_number] => 16/452353
[patent_app_country] => US
[patent_app_date] => 2019-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16452353
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/452353 | Cleavable lipids | Jun 24, 2019 | Issued |
Array
(
[id] => 17306350
[patent_doc_number] => 11207433
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-28
[patent_title] => Imaging agents and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/449147
[patent_app_country] => US
[patent_app_date] => 2019-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 8323
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16449147
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/449147 | Imaging agents and uses thereof | Jun 20, 2019 | Issued |
Array
(
[id] => 19134575
[patent_doc_number] => 11969484
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-30
[patent_title] => Composition containing a somatostatin analogue for radiopharmaceutical use
[patent_app_type] => utility
[patent_app_number] => 17/251426
[patent_app_country] => US
[patent_app_date] => 2019-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 7619
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17251426
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/251426 | Composition containing a somatostatin analogue for radiopharmaceutical use | Jun 19, 2019 | Issued |
Array
(
[id] => 19273280
[patent_doc_number] => 12023387
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-02
[patent_title] => NIR-II emissive luminogens
[patent_app_type] => utility
[patent_app_number] => 17/251961
[patent_app_country] => US
[patent_app_date] => 2019-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 21
[patent_no_of_words] => 5014
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17251961
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/251961 | NIR-II emissive luminogens | Jun 13, 2019 | Issued |
Array
(
[id] => 16941001
[patent_doc_number] => 11053222
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-06
[patent_title] => Fluorescent compounds
[patent_app_type] => utility
[patent_app_number] => 16/436512
[patent_app_country] => US
[patent_app_date] => 2019-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 81
[patent_no_of_words] => 25909
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16436512
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/436512 | Fluorescent compounds | Jun 9, 2019 | Issued |
Array
(
[id] => 18664915
[patent_doc_number] => 11771780
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Method for preparing an Fe-tCDTA contrast agent and product obtainable by the method
[patent_app_type] => utility
[patent_app_number] => 17/252261
[patent_app_country] => US
[patent_app_date] => 2019-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2376
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17252261
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/252261 | Method for preparing an Fe-tCDTA contrast agent and product obtainable by the method | Jun 5, 2019 | Issued |
Array
(
[id] => 15264933
[patent_doc_number] => 20190381200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => FREE PSA ANTIBODIES AS DIAGNOSTICS, PROGNOSTICS AND THERAPEUTICS FOR PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 16/430041
[patent_app_country] => US
[patent_app_date] => 2019-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16430041
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/430041 | Free PSA antibodies as diagnostics, prognostics and therapeutics for prostate cancer | Jun 2, 2019 | Issued |
Array
(
[id] => 16946793
[patent_doc_number] => 20210205484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => SPATIAL MAPPING OF KIDNEY FUNCTIONS
[patent_app_type] => utility
[patent_app_number] => 17/059606
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17059606
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/059606 | Spatial mapping of kidney functions | May 30, 2019 | Issued |
Array
(
[id] => 17748131
[patent_doc_number] => 20220226334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => ANTIBODY CONJUGATE AND APPLICATION OF PHARMACEUTICAL COMPOSITION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/612849
[patent_app_country] => US
[patent_app_date] => 2019-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13485
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17612849
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/612849 | ANTIBODY CONJUGATE AND APPLICATION OF PHARMACEUTICAL COMPOSITION THEREOF | May 20, 2019 | Abandoned |
Array
(
[id] => 16175596
[patent_doc_number] => 20200222564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => Compound Amphiphilic Peptide Nanomicelle, Preparation and Use Thereof
[patent_app_type] => utility
[patent_app_number] => 16/393784
[patent_app_country] => US
[patent_app_date] => 2019-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4109
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16393784
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/393784 | Compound Amphiphilic Peptide Nanomicelle, Preparation and Use Thereof | Apr 23, 2019 | Abandoned |
Array
(
[id] => 15206455
[patent_doc_number] => 20190365914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => NOVEL ANTIBODY-DRUG CONJUGATES AND THE USE OF SAME IN THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/381803
[patent_app_country] => US
[patent_app_date] => 2019-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15032
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 520
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16381803
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/381803 | Antibody-drug conjugates and the use of same in therapy | Apr 10, 2019 | Issued |
Array
(
[id] => 14833563
[patent_doc_number] => 20190275182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => RADIOTRACER COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 16/375223
[patent_app_country] => US
[patent_app_date] => 2019-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8054
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16375223
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/375223 | Radiotracer compositions and methods | Apr 3, 2019 | Issued |
Array
(
[id] => 14833549
[patent_doc_number] => 20190275175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => Carbon Nanotubes for Imaging and Drug Delivery
[patent_app_type] => utility
[patent_app_number] => 16/353743
[patent_app_country] => US
[patent_app_date] => 2019-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9591
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16353743
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/353743 | Carbon Nanotubes for Imaging and Drug Delivery | Mar 13, 2019 | Abandoned |